Nagel Batrafen A (Ciclopirox)

Ciclopirox acts by chelating intracellular metal ions that are essential for fungal sterol synthesis. This disruption impairs the formation of fungal cell membrane components, leading to loss of membrane integrity, leakage of cellular contents and ultimately fungal cell death across a broad range of dermatophytes, yeasts and molds.

The exact dosing regimen is determined by the prescribing healthcare professional. Typically, a thin layer of the product is applied to the affected skin once or twice daily, after washing and drying the area. The prescriber will advise the duration of treatment, which often ranges from two to four weeks depending on the infection.

Safety data for ciclopirox in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using the product. The prescriber may recommend alternative therapies if safety cannot be assured.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Nagel Batrafen A contains ciclopirox, which offers a broad spectrum of activity against dermatophytes, yeasts and molds, and works by a different mechanism than allylamine agents such as terbinafine. While both classes are effective, ciclopirox may be preferred for mixed infections or when resistance to other agents is a concern. Clinical choice depends on infection type, patient history and physician preference.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from excessive heat, moisture and direct sunlight. Keep the container tightly closed when not in use, and keep it out of reach of children. No refrigeration is required for this topical formulation.

Clean and thoroughly dry the affected skin area before use. Apply a thin, even layer of the cream or solution to the lesion and a small margin of surrounding skin. Gently rub it in until it disappears. Wash hands after application unless the hands are the treatment site. Follow the prescriber’s instructions regarding frequency and duration.

Although rare, serious adverse reactions can include allergic contact dermatitis, severe skin swelling, blistering or bullous eruptions, and systemic hypersensitivity responses. If any of these occur, discontinue the product immediately and seek medical attention. Prompt reporting of severe skin reactions helps prevent complications.

Individuals with a known hypersensitivity to ciclopirox or any component of the formulation should avoid using the product. It should also not be applied to broken, ulcerated or severely inflamed skin, nor to mucous membranes such as the eyes, ears or genital area. Children under the age recommended by the prescriber should not use it without medical guidance.